Evaluation agreement with Nitto Denko Avecia

Read the press release.

Codexis signs lease for GMP Manufacturing Facility

Read the press release

Home / Transformational Technologies

Modernizing Manufacturing for What's Next

Manufacturing solutions once thought unsolvable — powered by ECO Synthesis® Manufacturing Platform and CodeEvolver® Technology Platform.

graphic

Every Capability is Intentionally Engineered for Technical Edge

It’s not plug-and-play. It’s precision-built. Our proprietary platforms combine deep enzymology with AI and machine learning to deliver smarter science and repeatable success. From process transformation to product viability, we modernize manufacturing with platforms engineered for what others can’t replicate.

Platforms Built on Industry-Defining Science

Our proprietary transformational technologies pair enzyme know-how with machine learning, delivering smarter science and repeatable success that scales.

CodeEvolver Technology Platform

Driving enzyme performance with proprietary AI and machine learning — for screening kits, panels, and bespoke enzymes for small molecule APIs and molecular biology and diagnostic applications.

ECO Synthesis Manufacturing Platform

Enabling greener, scalable RNA manufacturing. With improved yield, quality, and manufacturability, while increasing sustainability for next-gen oligonucleotide-based therapies.

Combining Bold Innovation with Scientific Legacy

We’ve spent over 20 years refining the science of enzyme engineering and pushing the boundaries of therapeutic manufacturing. Our legacy of innovation — proven across platforms, programs, and partnerships — powers the next generation of real-world solutions.

Explore Our Engineered Advantage

Learn more about how our proprietary approach delivers results other platforms can’t replicate.

Unlocking the Future of RNA Manufacturing: A Guide to Enzymatic Synthesis

Enzymes to enable a biocatalytic cascade for small molecule API

Machine learning-guided ligation fragment design for efficient siRNA synthesis

Comparative analysis of diastereomeric distribution in siRNA synthesis: SPOS vs enzymatic synthesis

Oligonucleotide CMC for sustainable and scalable enzymatic siRNA manufacturing​

Process Development for Enzymatic Synthesis of RNAi Therapeutics

graphic

Discover the Engine Powering Scalable Solutions

Learn more about how our proprietary approach offers solutions that others can’t replicate. Let’s talk.

graphic